Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter ended March 31, 2019
Filing Date: May 21, 2019
This filing serves as a cover document referencing the company's full financial results and management analysis for the quarter ended March 31, 2019. The detailed financial data is contained within the attached exhibits, specifically the Media Release, Management's Analysis of Results, and Consolidated Financial Statements.
Key Financial Metrics
The provided text is a cover document and exhibit index; it does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced exhibits (99.2, 99.3, and 99.5) which are not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the "Management's Analysis of Results" (Exhibit 99.3) for comparative performance data.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing contains extensive forward-looking statements regarding future performance, capital expenditure projects, credit facility renewals, dividend payments, and share buy-backs.
Key Risks and Contingencies:
- Asbestos Liability: Significant exposure related to prior manufacture of asbestos-containing products, including required contributions to the Asbestos Injury Compensation Fund (AICF) and potential shortfalls.
- Legal Proceedings: Risks associated with product liability, environmental matters, and consumer class actions.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
- Operational Risks: Integration of Fermacell, raw material costs, and currency exchange rate fluctuations.
- Regulatory: Changes in tax laws, environmental regulations, and health and safety laws.
Unusual Items: The text notes expectations concerning costs associated with the suspension or closure of operations at certain plants and significant capital expenditure projects.
Investor Verification Checklist
- Verify specific revenue and profit figures in the "Media Release" (Exhibit 99.2) and "Consolidated Financial Statements" (Exhibit 99.5).
- Review the "KPMG Actuarial" report (Exhibit 99.6) for updated asbestos liability estimates and AICF contribution requirements.
- Confirm the status of the Fermacell integration and any associated costs in the "Management's Analysis of Results" (Exhibit 99.3).
- Check the "Notification of Dividend / Distribution" (Exhibit 99.7) for details on shareholder returns.
- Assess the impact of currency exchange rates on the company's financial statements, particularly regarding the Australian asbestos liability.